GlobeNewswire PharmaOriginal article
Curanex Highlights Five Additional Patient Cases Further Supporting the Potential of Its Lead Candidate in Cancer Cachexia, Advanced Cancer Supportive Care and Severe Systemic Decline
Data ReadoutpositivePositive
AI Analysis
Summary
Curanex presented five additional patient cases supporting its lead candidate for cancer cachexia and advanced cancer supportive care, including cases from thymic carcinoma, small cell lung cancer, pancreatic cancer, liver cirrhosis, and renal disease. The expanded case series provides observational evidence for the drug's potential across multiple disease indications.
Clinical Trial Data
Patients
5
Outcome Details
Expanded case series with five additional patient cases across advanced thymic carcinoma, small cell lung cancer, pancreatic cancer, end-stage liver cirrhosis, and end-stage renal disease
Importance:4/10
Sentiment:
0.60
cancer cachexiasupportive carecase serieslead candidateoncology
Related Companies
Read the original article
Published by GlobeNewswire Pharma on April 8, 2026 11:47 AM